Impf-Info - der blog
Novavax: EMA empfiehlt Novavax für Jugendliche - passend zum gerade untersuchten Verdacht des Myokarditis-Risikos...
s. dazu hier
EMA recommends Novavax COVID vaccine for adolescents | Reuters
The advisory committee to the European Union's drug regulator on Thursday recommended expanding the use of Novavax Inc's COVID-19 vaccine for adolescents aged 12 to 17 years.
By accepting you will be accessing a service provided by a third-party external to https://impf-info.de/